120 related articles for article (PubMed ID: 32141537)
1. CircAGFG1 aggravates the progression of cervical cancer by downregulating p53.
Wang XH; Li J
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1704-1711. PubMed ID: 32141537
[TBL] [Abstract][Full Text] [Related]
2. CircAGFG1 promotes cervical cancer progression via miR-370-3p/RAF1 signaling.
Wu F; Zhou J
BMC Cancer; 2019 Nov; 19(1):1067. PubMed ID: 31703640
[TBL] [Abstract][Full Text] [Related]
3. LncRNA FOXD2-AS1 accelerates the progression of cervical cancer via downregulating CDX1.
Chen DZ; Wang TF; Dai WC; Xu X; Chen PF
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10234-10240. PubMed ID: 31841177
[TBL] [Abstract][Full Text] [Related]
4. LncRNA LINC00673 inhibits p53 expression by interacting with EZH2 and DNMT1 in papillary thyroid carcinoma.
Meng XF; Zhao LY; Chu XF
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2075-2083. PubMed ID: 30915752
[TBL] [Abstract][Full Text] [Related]
5. LncRNA TUG1 aggravates the progression of cervical cancer by binding PUM2.
Duan W; Nian L; Qiao J; Liu NN
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8211-8218. PubMed ID: 31646551
[TBL] [Abstract][Full Text] [Related]
6. LINC01116 promotes proliferation, invasion and migration of osteosarcoma cells by silencing p53 and EZH2.
Zhang ZF; Xu HH; Hu WH; Hu TY; Wang XB
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6813-6823. PubMed ID: 31486480
[TBL] [Abstract][Full Text] [Related]
7. Upregulated lncRNA CACNA1G-AS1 aggravates the progression of colorectal cancer by downregulating p53.
Wei LJ; Bai DM; Wang ZY; Liu BC
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):130-136. PubMed ID: 31957825
[TBL] [Abstract][Full Text] [Related]
8. Linc-UBC1 stimulates the metastasis and progression of ovarian cancer via downregulating p53 level.
Liu H; Zeng SY; Xie Y; Fei CQ; Sun L
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1054-1061. PubMed ID: 32096175
[TBL] [Abstract][Full Text] [Related]
9. Guanosine monophosphate synthase upregulation mediates cervical cancer progression by inhibiting the apoptosis of cervical cancer cells via the Stat3/P53 pathway.
Wang J; Wu Y; Li Y; Wang Y; Shen F; Zhou J; Chen Y
Int J Oncol; 2021 Apr; 58(4):. PubMed ID: 33649833
[TBL] [Abstract][Full Text] [Related]
10. Musashi-2, a novel oncoprotein promoting cervical cancer cell growth and invasion, is negatively regulated by p53-induced miR-143 and miR-107 activation.
Dong P; Xiong Y; Hanley SJB; Yue J; Watari H
J Exp Clin Cancer Res; 2017 Oct; 36(1):150. PubMed ID: 29073938
[TBL] [Abstract][Full Text] [Related]
11. CircAGFG1 sponges miR-203 to promote EMT and metastasis of non-small-cell lung cancer by upregulating ZNF281 expression.
Xue YB; Ding MQ; Xue L; Luo JH
Thorac Cancer; 2019 Aug; 10(8):1692-1701. PubMed ID: 31243884
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA GClnc1 promotes progression of colorectal cancer by inhibiting p53 signaling pathway.
Dong YX; Pang ZG; Zhang JC; Hu JQ; Wang LY
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5705-5713. PubMed ID: 31298323
[TBL] [Abstract][Full Text] [Related]
13. The carcinogenic complex lncRNA DUXAP8/EZH2/LSD1 accelerates the proliferation, migration and invasion of colorectal cancer.
Gong A; Huang Z; Ge H; Cai Y; Yang C
J BUON; 2019; 24(5):1830-1836. PubMed ID: 31786844
[TBL] [Abstract][Full Text] [Related]
14. LINC00511 promotes the progression of non-small cell lung cancer through downregulating LATS2 and KLF2 by binding to EZH2 and LSD1.
Zhu FY; Zhang SR; Wang LH; Wu WD; Zhao H
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8377-8390. PubMed ID: 31646568
[TBL] [Abstract][Full Text] [Related]
15. LINC00702 accelerates the progression of ovarian cancer through interacting with EZH2 to inhibit the transcription of KLF2.
Wang L; Ye TY; Wu H; Chen SY; Weng JR; Xi XW
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):201-208. PubMed ID: 31389610
[TBL] [Abstract][Full Text] [Related]
16. LncRNA SNHG8 accelerates proliferation and inhibits apoptosis in HPV-induced cervical cancer through recruiting EZH2 to epigenetically silence RECK expression.
Qu X; Li Y; Wang L; Yuan N; Ma M; Chen Y
J Cell Biochem; 2020 Oct; 121(10):4120-4129. PubMed ID: 31961005
[TBL] [Abstract][Full Text] [Related]
17. lncRNA PICART1 alleviates progression of cervical cancer by upregulating TCF21.
Zhao Y; Dong X; Hou R
Oncol Lett; 2020 Jun; 19(6):3719-3724. PubMed ID: 32382324
[TBL] [Abstract][Full Text] [Related]
18. EZH2-mediated repression of GSK-3β and TP53 promotes Wnt/β-catenin signaling-dependent cell expansion in cervical carcinoma.
Chen Q; Zheng PS; Yang WT
Oncotarget; 2016 Jun; 7(24):36115-36129. PubMed ID: 27092879
[TBL] [Abstract][Full Text] [Related]
19. F-box protein FBXO31 modulates apoptosis and epithelial-mesenchymal transition of cervical cancer via inactivation of the PI3K/AKT-mediated MDM2/p53 axis.
Liu K; Xue B; Bai G; Zhang W
Life Sci; 2020 Oct; 259():118277. PubMed ID: 32800832
[TBL] [Abstract][Full Text] [Related]
20. Long Noncoding RNA
Chi C; Li M; Hou W; Chen Y; Zhang Y; Chen J
Cancer Biother Radiopharm; 2020 Jun; 35(5):329-337. PubMed ID: 32275170
[No Abstract] [Full Text] [Related]
[Next] [New Search]
